Inventor · Hanover, NH, US

Ke Liu

54Patents
5h-index
100Co-inventors
75Inventor score

Filing activity: Aug 12, 1993 → Jul 22, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US5494030A Apparatus and methodology for determining oxygen in biological systems Physics 139 Expired
US5833601A Methodology for determining oxygen in biological systems Physics 91 Expired
US9044451B2 Use of delta tocopherol for the treatment of lysosomal storage disorders Human Necessities 32 Active
US5706805A Apparatus and methodology for determining oxygen tension in biological systems Physics 24 Expired
US11358999B2 IL-12 heterodimeric Fc-fusion proteins Chemistry; Metallurgy 7 Active
US10923214B2 Neural network for predicting drug property Physics 5 Active
US11261178B2 Chroman derivatives having estrogen receptor degradation activity and uses thereof Chemistry; Metallurgy 5 Active
US11420956B2 Ureas having Androgen Receptor degradation activity and uses thereof Chemistry; Metallurgy 4 Active
US7381405B2 Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer Chemistry; Metallurgy 3 Expired
US11535606B2 Substituted quinoline-8-carbonitrile derivatives with androgen receptor degradation activity and uses thereof Chemistry; Metallurgy 3 Active
US11312702B2 Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereof Chemistry; Metallurgy 3 Active
US7223604B1 Methods and kits for the detection of erythrocytes Physics 2 Expired
US9526930B2 Control method of a fire truck for high-rise and super high-rise building firefighting Performing Operations; Transporting 2 Active
US11851466B2 Targeted IL-12 heterodimeric Fc-fusion proteins Chemistry; Metallurgy 2 Active
US9944632B2 Compounds having estrogen receptor alpha degradation activity and uses thereof Chemistry; Metallurgy 2 Active
US11220490B2 Ureas having androgen receptor degradation activity and uses thereof Chemistry; Metallurgy 1 Active
US10550103B2 Dual inhibitors of PARP1 and CDK Chemistry; Metallurgy 1 Active
US11618776B2 Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA and NKG2D antigen binding domains Chemistry; Metallurgy 1 Active
US10364507B2 Nanopore forming method and uses thereof Physics 1 Active
US10696659B2 Compounds having estrogen receptor alpha degradation activity and uses thereof Chemistry; Metallurgy 1 Active
US9393312B2 Amphiphilic block copolymer and preparation method thereof and micellar drug-loading system formed by same with antitumor drug Chemistry; Metallurgy 1 Active
US10800770B1 Chroman derivatives having estrogen receptor degradation activity and uses thereof Chemistry; Metallurgy 1 Active
US9606129B2 Blood biomarker for early blood brain barrier disruption in ischemic stroke Physics 1 Active
US9599625B2 Blood biomarker for early blood brain barrier disruption in ischemic stroke Physics 1 Active
US10836749B1 Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereof Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.